DK2138848T3 - Fremgangsmåde til diagnose og/eller prognose af blærecancer - Google Patents

Fremgangsmåde til diagnose og/eller prognose af blærecancer

Info

Publication number
DK2138848T3
DK2138848T3 DK07788578.8T DK07788578T DK2138848T3 DK 2138848 T3 DK2138848 T3 DK 2138848T3 DK 07788578 T DK07788578 T DK 07788578T DK 2138848 T3 DK2138848 T3 DK 2138848T3
Authority
DK
Denmark
Prior art keywords
bladder cancer
prognosis
diagnosis
procedure
quantification
Prior art date
Application number
DK07788578.8T
Other languages
English (en)
Inventor
Asensio Antonio Alcaraz
Brichs Lourdes Mengual
Albareda Moises Burset
Caparros Maria Jose Ribal
Criach Elisabet Ars
Original Assignee
Fina Biotech Slu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fina Biotech Slu filed Critical Fina Biotech Slu
Application granted granted Critical
Publication of DK2138848T3 publication Critical patent/DK2138848T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07788578.8T 2007-03-20 2007-06-05 Fremgangsmåde til diagnose og/eller prognose af blærecancer DK2138848T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200700727A ES2304306B1 (es) 2007-03-20 2007-03-20 Metodo de diagnostico y/o pronostico de cancer vesical.
PCT/ES2007/000330 WO2008113870A1 (es) 2007-03-20 2007-06-05 Método de diagnóstico y/o pronóstico de cancer vesical

Publications (1)

Publication Number Publication Date
DK2138848T3 true DK2138848T3 (da) 2011-02-21

Family

ID=39758544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07788578.8T DK2138848T3 (da) 2007-03-20 2007-06-05 Fremgangsmåde til diagnose og/eller prognose af blærecancer

Country Status (13)

Country Link
US (1) US9097715B2 (da)
EP (1) EP2138848B1 (da)
JP (1) JP5314667B2 (da)
CN (1) CN101730848A (da)
AT (1) ATE487140T1 (da)
CA (1) CA2693847C (da)
DE (1) DE602007010360D1 (da)
DK (1) DK2138848T3 (da)
ES (2) ES2304306B1 (da)
PL (1) PL2138848T3 (da)
PT (1) PT2138848E (da)
SI (1) SI2138848T1 (da)
WO (1) WO2008113870A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009335000B2 (en) * 2008-12-30 2014-11-13 Children's Medical Center Corporation Method of predicting acute appendicitis
US20120053253A1 (en) * 2010-07-07 2012-03-01 Myriad Genetics, Incorporated Gene signatures for cancer prognosis
US8987423B2 (en) * 2010-07-22 2015-03-24 Glaxosmithkline Biologicals, S.A. MAGE antigen binding proteins
EP2663656B1 (en) * 2011-01-13 2016-08-24 Decode Genetics EHF Genetic variants as markers for use in urinary bladder cancer risk assessment
WO2012178087A1 (en) * 2011-06-22 2012-12-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of bladder cancer
US9249467B2 (en) 2011-09-16 2016-02-02 Steven Goodison Bladder cancer detection composition, kit and associated methods
WO2013040758A1 (zh) * 2011-09-20 2013-03-28 深圳华大基因科技有限公司 膀胱移行细胞癌易感性的相关基因及其预测方法和系统
AU2012340393B2 (en) * 2011-11-15 2018-06-14 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of bladder cancer
ES2601460T3 (es) 2011-12-30 2017-02-15 Abbott Molecular Inc. Materiales y métodos para el diagnóstico del cáncer de vejiga y el control de la recurrencia del mismo
ES2619032T3 (es) 2012-04-20 2017-06-22 Cepheid Métodos de detección del cáncer de vejiga
EP2762574A1 (en) 2013-01-31 2014-08-06 Fina Biotech, S.L. Non-invasive diagnostic method for diagnosing bladder cancer
JP2016513961A (ja) * 2013-03-06 2016-05-19 セファイド 膀胱癌を検出する方法
WO2015013233A2 (en) * 2013-07-23 2015-01-29 Oncocyte Corp Methods and compositions for the treatment and diagnosis of bladder cancer
US10304188B1 (en) 2015-03-27 2019-05-28 Caleb J. Kumar Apparatus and method for automated cell analysis
JP6854246B2 (ja) 2015-06-08 2021-04-07 アーケア ダイアグノスティクス リミテッド 尿サンプルの分析方法
EP3304084B1 (en) 2015-06-08 2022-03-23 Arquer Diagnostics Limited Methods and kits
EP3332027A1 (en) * 2015-08-06 2018-06-13 Stichting Katholieke Universiteit Method for the prediction of progression of bladder cancer
CN105368959B (zh) * 2015-12-15 2019-01-04 甘肃中天羊业股份有限公司 Anxa10基因作为绵羊免疫性状的分子标记及其应用
WO2018218737A1 (zh) * 2017-06-01 2018-12-06 立森印迹诊断技术（无锡）有限公司 一种印记基因在膀胱肿瘤中的分级模型及其组成的系统
WO2018219342A1 (zh) * 2017-06-01 2018-12-06 立森印迹诊断技术有限公司 一种印记基因分级模型和诊断方法及其应用
CN108414755A (zh) * 2017-10-25 2018-08-17 深圳市罗湖区人民医院 一种同时检测尿液中四个膀胱癌标志物的蛋白芯片
CN108414756A (zh) * 2017-10-25 2018-08-17 深圳市罗湖区人民医院 一种同时检测尿液中四个膀胱癌标志物的蛋白芯片的制备方法
CN108866194B (zh) 2018-08-16 2021-03-26 杭州可帮基因科技有限公司 一组用于膀胱癌检测的基因及其应用
CN109797221A (zh) * 2019-03-13 2019-05-24 上海市第十人民医院 一种用于对肌层浸润性膀胱癌进行分子分型和/或预后预测的生物标记物组合及其应用
CN112378708B (zh) * 2020-11-04 2024-03-26 中国人民解放军陆军装甲兵学院 一种基于Bayes方法小样本条件下装备评估装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318504B1 (it) * 2000-05-08 2003-08-27 Talent Srl Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.

Also Published As

Publication number Publication date
US9097715B2 (en) 2015-08-04
JP5314667B2 (ja) 2013-10-16
EP2138848A4 (en) 2010-03-31
EP2138848B1 (en) 2010-11-03
ES2304306B1 (es) 2009-07-07
JP2010521981A (ja) 2010-07-01
EP2138848A1 (en) 2009-12-30
CA2693847C (en) 2016-08-02
SI2138848T1 (sl) 2011-04-29
ATE487140T1 (de) 2010-11-15
CA2693847A1 (en) 2008-09-25
CN101730848A (zh) 2010-06-09
PL2138848T3 (pl) 2011-11-30
ES2304306A1 (es) 2008-10-01
PT2138848E (pt) 2011-02-08
DE602007010360D1 (de) 2010-12-16
ES2357784T3 (es) 2011-04-29
WO2008113870A1 (es) 2008-09-25
US20100086932A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
DK2138848T3 (da) Fremgangsmåde til diagnose og/eller prognose af blærecancer
WO2009069984A3 (en) Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
DK2223115T3 (da) Seprase som markør for cancer
GB2488700B (en) Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual
ATE533061T1 (de) Verfahren zur diagnose bakterieller infektionen
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
UY32698A (es) Marcadores de riesgo para enfermedades cardiovasculares
TW200741010A (en) Method for predicting the response to a treatment
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
BRPI0513692B8 (pt) processos para detecção de câncer de bexiga em um indivíduo
WO2008079269A3 (en) Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom
ATE412905T1 (de) Diagnoseverfahren für lebersteatose unter verwendung biochemischer marker
DE602006018578D1 (de) Diagnose- und prognoseverfahren von blasenkrebs.
FI2398902T3 (fi) Menetelmiä ja koostumuksia syövän diagnoosia ja hoitoa varten
WO2005067391A3 (en) Diagnostic test for parkinson's disease
WO2009019368A3 (fr) Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal
ATE554389T1 (de) Apex als marker für lungenkrebs
WO2007133551A3 (en) Method for testing drug sensitivity in solid tumors by quantifying mrna expression in thinly-sliced tumor tissue
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
DK2140021T3 (da) Fremgangsmåder til detektion af inflammatorisk tarmsygdom.
JP2009524829A5 (da)
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
AU2010202926B2 (en) Markers and methods relating to the assessment of Alzheimer's disease
DE602006020850D1 (de) Biomarker zur diagnose einer herzerkrankung sowie verwendung davon
WO2012056451A3 (en) Peripheral blood gene markers for early diagnosis of parkinson's disease